Cargando…

Correction: Two-stage matching-adjusted indirect comparison

Detalles Bibliográficos
Autor principal:	Remiro‑Azócar, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624027/ https://www.ncbi.nlm.nih.gov/pubmed/36316639 http://dx.doi.org/10.1186/s12874-022-01753-z

Ejemplares similares

Two-stage matching-adjusted indirect comparison
por: Remiro-Azócar, Antonio
Publicado: (2022)

Parametric G‐computation for compatible indirect treatment comparisons with limited individual patient data
por: Remiro‐Azócar, Antonio, et al.
Publicado: (2022)

Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis
por: Armstrong, April W., et al.
Publicado: (2023)

Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison
por: Wong, Raymond, et al.
Publicado: (2023)

Some considerations on target estimands for health technology assessment
por: Remiro‐Azócar, Antonio
Publicado: (2022)

Equivalence of entropy balancing and the method of moments for matching‐adjusted indirect comparison
por: Phillippo, David M., et al.
Publicado: (2020)

A Critical Appraisal of Matching-Adjusted Indirect Comparisons in Spinal Muscular Atrophy
por: Jiang, Tammy, et al.
Publicado: (2023)

Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: a matching-adjusted indirect comparison
por: Signorovitch, James, et al.
Publicado: (2013)

Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparison
por: Maksymowych, Walter P., et al.
Publicado: (2018)

A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma
por: Odom, Dawn, et al.
Publicado: (2017)

Matching-adjusted indirect comparison of the pelabresib-ruxolitinib combination vs JAKi monotherapy in myelofibrosis
por: Gupta, Vikas, et al.
Publicado: (2023)

Correction: Extended two-stage designs for environmental research
por: Sera, Francesco, et al.
Publicado: (2022)

Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
por: Strand, Vibeke, et al.
Publicado: (2017)

Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2− advanced breast cancer
por: Tremblay, Gabriel, et al.
Publicado: (2018)

A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis
por: Edwards, Christopher J., et al.
Publicado: (2020)

Correction to: Applied comparison of large-scale propensity score matching and cardinality matching for causal inference in observational research
por: Fortin, Stephen P., et al.
Publicado: (2021)

Matching-Adjusted Indirect Comparison of Blinatumomab vs. Inotuzumab Ozogamicin for Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
por: Song, Jinlin, et al.
Publicado: (2019)

Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis
por: Armstrong, April W., et al.
Publicado: (2023)

Matching-adjusted indirect comparisons of efficacy of BAY 81-8973 vs two recombinant factor VIII for the prophylactic treatment of severe hemophilia A
por: Pocoski, Jennifer, et al.
Publicado: (2016)

Correction: The Earliest Matches
por: Goren-Inbar, Naama, et al.
Publicado: (2012)

Matching-adjusted indirect treatment comparison of the efficacy of enzalutamide versus apalutamide for the treatment of nonmetastatic castration-resistant prostate cancer
por: Tombal, B., et al.
Publicado: (2022)

Correction: Direct and indirect savings from parallel imports in Sweden
por: Granlund, David
Publicado: (2022)

Matching-adjusted indirect comparison of benralizumab versus interleukin-5 inhibitors for the treatment of severe asthma: a systematic review
por: Bourdin, Arnaud, et al.
Publicado: (2018)

Performance of unanchored matching-adjusted indirect comparison (MAIC) for the evidence synthesis of single-arm trials with time-to-event outcomes
por: Jiang, Yawen, et al.
Publicado: (2020)

Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer
por: Chowdhury, Simon, et al.
Publicado: (2019)

Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison
por: Cohan, Stanley, et al.
Publicado: (2021)

Matching‐adjusted indirect comparison of isatuximab plus carfilzomib and dexamethasone with daratumumab plus lenalidomide and dexamethasone in relapsed multiple myeloma
por: Richter, Joshua, et al.
Publicado: (2023)

Matching-Adjusted Indirect Comparison Between Risankizumab and Ustekinumab for Induction and Maintenance Treatment of Moderately to Severely Active Crohn’s Disease
por: Dubinsky, Marla, et al.
Publicado: (2023)

Correction to: Two-step verification of brain tumor segmentation using watershed-matching algorithm
por: Hasan, S. M. Kamrul, et al.
Publicado: (2018)

Correction to: An Indirect Comparison of the Efficacy and Safety of Dostarlimab and Doxorubicin for the Treatment of Advanced and Recurrent Endometrial Cancer
Publicado: (2022)

Correction to: Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival
por: Weber, Jeffrey S., et al.
Publicado: (2022)

Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy
por: Llibre, Josep M., et al.
Publicado: (2016)

Correction to: Indirect and direct routes to C-glycosylated flavones in Saccharomyces cerevisiae
por: Vanegas, Katherina Garcia, et al.
Publicado: (2018)

Correction to: Esmolol indirectly stimulates vagal nerve activity in endotoxemic pigs
por: Aboab, Jerome, et al.
Publicado: (2018)

Correction to: Substrate utilization and energy expenditure pattern in sepsis by indirect calorimetry
por: Li, Andrew, et al.
Publicado: (2020)

Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors
por: Atallah, Ehab, et al.
Publicado: (2023)

Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal
por: Phillippo, David M., et al.
Publicado: (2017)

Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphoma
por: Maloney, David G., et al.
Publicado: (2021)

Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison
por: Ribera, Josep-Maria, et al.
Publicado: (2023)

Correction to: Development of a data-driven case-mix adjustment model for comparison of hospital performance in hip fracture care
por: Würdemann, Franka S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g3rmbvge1s2bnftsqhibn171su